Delivery Order SPE2DB22D1017-SPE2DB25FYRBQ
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $4,687.18 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Tezspire 210 mg/1.91 mL pens. This is a firm fixed-price, non-set-aside contract with performance scheduled for completion by September 19, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectables. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion deadline of August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $4.7K delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injections. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 29, 2025, and will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $18,748.72 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with performance completion by September 30, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger federal contracting vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors. This firm fixed price contract, with an ultimate completion date of August 4, 2025, represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was made through competitive procurement with no set-aside designation, and performance will occur at the vendor's...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors with an ultimate completion date of September 11, 2025. This competitive award was issued under a firm fixed-price contract structure with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order...
- The Defense Logistics Agency awarded a $35,153.85 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectors. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of September 3, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,687.18 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen on August 27, 2025, with a completion date of September 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be supplied to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Tezspire 210 mg/1.91 mL pens with a ceiling value of $9,374.36. This firm fixed-price delivery order, with an ultimate completion date of October 3, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The award was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded a $9,374.36 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors, with completion scheduled for September 29, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader Indefinite...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRBQDelivery Order
The Defense Logistics Agency awarded a $4,687.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Tezspire 210 mg/1.91 mL pens. The contract, with an ultimate completion date of October 8, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This award was not set-aside and was competitively awarded. Performance of the contract will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's comprehensive pharmaceutical portfolio supports military healthcare systems and other federal customers with brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Tezspire, a biologic asthma and eosinophilic granulomatosis with polyangiitis treatment, exemplifies the company's role in supplying specialized healthcare commodities to support military personnel and veteran healthcare programs through the DLA's flexible contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 9/17/25 |